Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparative Effects of Human Neural Stem Cells and Oligodendrocyte Progenitor Cells on the Neurobehavioral Disorders of Experimental Autoimmune Encephalomyelitis Mice.
Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.
Acute Disseminated Encephalomyelitis Without Optic Neuritis Followed by Optic Neuritis in a Child Due to the Sudden Cessation of Steroid Therapy.
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.
VIP and PACAP: Neuropeptide modulators of CNS inflammation, injury, and repair.
Overexpression of SIRT1 Protein in Neurons Protects against Experimental Autoimmune Encephalomyelitis through Activation of Multiple SIRT1 Targets.
Variations in predicted risks in personal genome testing for common complex diseases.
Tumor Necrosis Factor-α Inhibitor Use in Psoriasis Patients With a First-degree Relative With Multiple Sclerosis.
Directional migration and transcriptional analysis of oligodendrocyte precursors subjected to stimulation of electrical signal.
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.
Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?
Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Demyelinating disease: Neurodegeneration distinguishes MS from NMO.
Biochemical Pharmacology of the Sigma-1 Receptor.
Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier.
Distinct roles of T-cell lymphopenia and the microbial flora for gastrointestinal and CNS autoimmunity.
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis.
Epidemiological characteristics and functional disability of multiple sclerosis patients in kosovo.
Urodynamic changes in mice with experimental autoimmune encephalomyelitis correlate with neurological impairment.
Neuromuscular manifestations of west nile virus infection.
Emerging stem cell therapies: treatment, safety, and biology.
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
Depressive syndromes in neurological disorders.
Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System.
Ice Pick Headache.
Pages
« first
‹ previous
…
537
538
539
540
541
542
543
544
545
…
next ›
last »